Stock SSKN STRATA SKIN SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings STRATA Skin Sciences, Inc.

Equities

SSKN

US86272A2069

Market Closed - Nasdaq
Other stock markets
 02:00:00 04/05/2024 am IST 		5-day change 1st Jan Change
0.4171 USD +4.28% Intraday chart for STRATA Skin Sciences, Inc. -18.93% -24.18%
29/04 STRATA Skin Sciences OKs 1-for-10 Reverse Split MT
09/04 STRATA Skin Sciences, Inc. Announces Renewal of Exclusive Distribution Agreements in China and Japan CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
STRATA SKIN SCIENCES, INC. Stock STRATA Skin Sciences, Inc.
-24.18% 14.62M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.84% 218B
B
DANAHER CORPORATION Stock Danaher Corporation
+7.35% 184B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.04% 135B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.03% 107B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-1.33% 62.38B
A-
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.9B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.30% 40.87B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.78% 36.28B -
RESMED, INC. Stock ResMed, Inc.
+26.14% 31.88B
B+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SSKN Stock
  4. Ratings STRATA Skin Sciences, Inc.